We are live on
!
Find out more
T
TOBAM Portfolio holdings
AUM
$412M
1-Year Est. Return
18.33%
This Fund
S&P 500
This Quarter
Est. Return
+30.56%
1 Year Est. Return
+18.33%
3 Year Est. Return
+56.05%
5 Year Est. Return
+49%
10 Year Est. Return
+255.15%
AUM
$1.55B
AUM Growth
+$290M
(+23%)
Cap. Flow
+$12.7M
Cap. Flow
% of AUM
0.82%
Top 10 Holdings %
Top 10 Hldgs %
27.14%
Holding
181
New
46
Increased
42
Reduced
54
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Conagra Brands
CAG
|
+$34.4M |
| 2 |
Teladoc Health
TDOC
|
+$32.2M |
| 3 |
Gilead Sciences
GILD
|
+$31.6M |
| 4 |
Clorox
CLX
|
+$26.7M |
| 5 |
Moderna
MRNA
|
+$21.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NextEra Energy
NEE
|
+$35.5M |
| 2 |
Edison International
EIX
|
+$32.2M |
| 3 |
Ulta Beauty
ULTA
|
+$20.9M |
| 4 |
AutoZone
AZO
|
+$19.7M |
| 5 |
Newmont
NEM
|
+$18.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 24.87% |
| 2 | Healthcare | 18.56% |
| 3 | Consumer Discretionary | 12.54% |
| 4 | Materials | 12.04% |
| 5 | Communication Services | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
CenterPoint Energy
CNP
$26.1B
| – | – |
-129,168
| Closed | -$2M |
|
152
Quest Diagnostics
DGX
$26.2B
| – | – |
-11,441
| Closed | -$919K |
|
153
Darden Restaurants
DRI
$24.6B
| – | – |
-74,607
| Closed | -$4.06M |
|
154
Exelon
EXC
$45B
| – | – |
-345,758
| Closed | -$9.08M |
|
155
Galicia Financial Group
GGAL
$7.13B
| – | – |
-15,868
| Closed | -$112K |
|
156
Halliburton
HAL
$30.9B
| – | – |
-165,432
| Closed | -$1.13M |
|
157
Hasbro
HAS
$13.1B
| – | – |
-53,895
| Closed | -$3.86M |
|
|
HUYA
158
Huya Inc
HUYA
$484M
| – | – |
-1,215
| Closed | -$21K |
|
159
Lear
LEA
$6.64B
| – | – |
-22,487
| Closed | -$1.83M |
|
160
Middleby
MIDD
$5.05B
| – | – |
-36,341
| Closed | -$2.07M |
|
161
NOV
NOV
$7.63B
| – | – |
-413,632
| Closed | -$4.07M |
|
|
PARA
162
DELISTED
Paramount Global Class B
PARA
| – | – |
-65,588
| Closed | -$919K |
|
|
SAGE
163
DELISTED
Sage Therapeutics
SAGE
| – | – |
-2,400
| Closed | -$69K |
|
|
SPR
164
DELISTED
Spirit AeroSystems
SPR
| – | – |
-19,883
| Closed | -$476K |
|
165
Sempra
SRE
$55B
| – | – |
-127,198
| Closed | -$7.19M |
|
166
SSR Mining
SSRM
$7.58B
| – | – |
-64,947
| Closed | -$732K |
|
167
Constellation Brands
STZ
$21.9B
| – | – |
-67,962
| Closed | -$9.74M |
|
168
Sysco
SYY
$38.4B
| – | – |
-37,680
| Closed | -$1.72M |
|
169
Teva Pharmaceuticals
TEVA
$42.4B
| – | – |
-102,004
| Closed | -$916K |
|
170
Tesla
TSLA
$1.4T
| – | – |
-155,070
| Closed | -$5.42M |
|
171
Trade Desk
TTD
$6.78B
| – | – |
-5,000
| Closed | -$97K |
|
172
Under Armour
UAA
$2.26B
| – | – |
-59,529
| Closed | -$548K |
|
173
US Foods
USFD
$22.5B
| – | – |
-1,855
| Closed | -$33K |
|
174
Ventas
VTR
$46.3B
| – | – |
-552,592
| Closed | -$14.8M |
|
175
W.P. Carey
WPC
$16B
| – | – |
-36,735
| Closed | -$2.09M |
|
Similar funds
EC
WIP
KP
MP
AWP
THCM
PA
HP
TOBAM's Q2 2020 Portfolio in Review
As of Q2 2020, TOBAM held 181 positions worth $1.55B, up 23% from $1.26B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
TOBAM's Q2 2020 filing shows 46 new, 42 increased, 54 reduced and 38 closed positions. Its largest new stake was Teladoc Health: 183,779 shares worth $35.1M. The largest sale was NextEra Energy, an estimated $35.5M.
By sector, the portfolio is most concentrated in Consumer Staples at 25% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- TOBAM's largest Q2 2020 buy was Teladoc Health: 183,779 shares worth $35.1M.
- TOBAM added most to Conagra Brands in Q2 2020, an estimated $34.4M increase.
- TOBAM's biggest Q2 2020 reduction was NextEra Energy, cutting an estimated $35.5M.
- TOBAM fully exited Ventas in Q2 2020, selling an estimated $14.8M.
- TOBAM's ten largest holdings make up 27% of its $1.55B portfolio in Q2 2020.
- TOBAM opened 46 new positions and closed 38 in Q2 2020.
- TOBAM's portfolio value rose 23% quarter-over-quarter to $1.55B.
Based on TOBAM's 13F filing for Q2 2020, filed 17 Aug 2020.